SCHEMBL13604129

SCHEMBL13604129

CC1(C)OB(c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)OC1(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
TBXA2R P21731 2/20 0.55
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA9 Q16790 1/20 0.54
ALDH1A1 P00352 6/20 0.51
PRMT1 Q99873 1/20 0.51
PPARG P37231 3/20 0.50
LSS P48449 1/20 0.50
POLB P06746 1/20 0.49
TP53 P04637 1/20 0.49
GAA P10253 1/20 0.49
LPL P06858 1/20 0.49
LIPG Q9Y5X9 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13604136 0.89 ALDH1A1 (0.68) MEN1KMT2ACA1CA2CA9
SCHEMBL13604125 0.88 ALDH1A1 (0.58) MEN1KMT2ACA1CA2CA9
SCHEMBL13604114 0.88 ALDH1A1 (0.56) MEN1KMT2ATBXA2RCA1CA2
SCHEMBL13604127 0.86 AKR1C3 (0.50) MEN1KMT2ACA1CA2CA9
SCHEMBL13604138 0.86 ALDH1A1 (0.70) MEN1KMT2ACA1CA2CA9
SCHEMBL13604139 0.85 CA1 (0.62) MEN1KMT2ATBXA2RCA1CA2
SCHEMBL13611678 0.85 LSS (0.57) MEN1KMT2ACA1CA2CA9
SCHEMBL13611732 0.81 MEN1 (0.60) MEN1KMT2ATBXA2RCA1CA2
SCHEMBL9754552 0.81 MEN1 (0.84) MEN1KMT2ATBXA2RCA1CA2
SCHEMBL13604132 0.81 LPL (0.47) KMT2ACA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625932-B2 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors ELI LILLY AND COMPANY (US) 2009-12-01 US disclosed
US-20070066573-A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors ELI LILLY AND COMPANY 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066573-A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors GRIN1, GRIN3A, GRIK5 MEN1 4720/4885KMT2A 3400/4885TBXA2R 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.